Last reviewed · How we verify
PREMPRO/PREMPHASE (CONJUGATED ESTROGENS/MEDROXYPROGESTERONE ACETATE)
PREMPRO/PREMPHASE (generic name: CONJUGATED ESTROGENS/MEDROXYPROGESTERONE ACETATE) is a drug developed by WYETH AYERST. It is currently FDA-approved.
At a glance
| Generic name | CONJUGATED ESTROGENS/MEDROXYPROGESTERONE ACETATE |
|---|---|
| Sponsor | WYETH AYERST |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- An Open-Label, Single-Dose, Randomized, 4-Period, Crossover, Bioavailability Study Among 3 New Formulations of Premarin 0.625 mg/Medroxyprogesterone Acetate (Mpa) 2.5 mg Compared With a Reference Form (Phase 1)
- Heart and Estrogen-Progestin Replacement Study (HERS) (Phase 3)
- The Estrogen Replacement and Atherosclerosis Trial (Phase 3)
- NCT00000466 (Phase 3)
- Safety of Estrogens in Lupus Erythematosus - National Assessment (SELENA): Hormone Replacement Therapy (Phase 3)
- Herbal Alternatives for Menopause Symptoms: A Randomized Trial (Phase 4)
- Prospective Double Blind Evaluation of Bioidentical Hormones (Phase 2)
- Open-Label, Single-Dose, Partially Randomized, 6-Period, 6-Treatment, Crossover Bioavailability Study of 3 Pilot Formulations of Premarin®/Medroxyprogesterone Acetate (MPA) Compared With Reference For (Phase 1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PREMPRO/PREMPHASE CI brief — competitive landscape report
- PREMPRO/PREMPHASE updates RSS · CI watch RSS
- WYETH AYERST portfolio CI
Frequently asked questions about PREMPRO/PREMPHASE
What is PREMPRO/PREMPHASE?
PREMPRO/PREMPHASE (CONJUGATED ESTROGENS/MEDROXYPROGESTERONE ACETATE) is a pharmaceutical drug developed by WYETH AYERST.
Who makes PREMPRO/PREMPHASE?
PREMPRO/PREMPHASE is developed and marketed by WYETH AYERST (see full WYETH AYERST pipeline at /company/wyeth-ayerst).
What is the generic name of PREMPRO/PREMPHASE?
CONJUGATED ESTROGENS/MEDROXYPROGESTERONE ACETATE is the generic (nonproprietary) name of PREMPRO/PREMPHASE.
What development phase is PREMPRO/PREMPHASE in?
PREMPRO/PREMPHASE is FDA-approved (marketed).
Related
- Manufacturer: WYETH AYERST — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing